Silji Abraham - 20 Feb 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP, Chief Technology Officer
Signature
/s/ Luis Cantarero
Issuer symbol
WST
Transactions as of
20 Feb 2024
Net transactions value
$0
Form type
4
Filing time
22 Feb 2024, 18:16:07 UTC
Previous filing
10 Aug 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Award $0 +646 +16% $0.000000 4,660 20 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Award $0 +2,968 $0.000000 2,968 20 Feb 2024 Stock Options (Right to Buy) 2,968 $350.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2021 PSUs (PP20) award vesting net of taxes withheld.
F2 This grant vests in four equal installments beginning on February 20, 2025.